Dynasore: Noncompetitive Dynamin GTPase Inhibitor for Endocytosis Research

Executive Summary: Dynasore, a noncompetitive inhibitor of dynamin GTPases supplied by APExBIO, selectively inhibits dynamin1, dynamin2, and Drp1 with an IC50 of 15 µM, blocking dynamin-dependent endocytosis in mammalian and invertebrate cells (Wei et al., 2019, DOI). Its action has been validated through reversible inhibition of transferrin uptake and synaptic vesicle endocytosis, and it is effective in diverse cell models such as HL-1 cells and neurons. Dynasore is soluble in DMSO but insoluble in water and ethanol, requiring careful stock preparation and storage at -20°C (APExBIO product page). Extensive benchmarking affirms its role in elucidating vesicle trafficking, signal transduction, and disease-relevant pathways across cancer and neurodegenerative research (internal article).

Biological Rationale

Endocytosis is a fundamental cellular process that regulates nutrient uptake, receptor recycling, and signal transduction. Dynamin proteins (dynamin1, dynamin2, and Drp1) are large GTPases essential for the scission of vesicles from cellular membranes. Inhibition of dynamin function disrupts clathrin-mediated and other forms of endocytosis, impacting vesicle trafficking, protein biosynthesis, and intracellular signaling (Wei et al., 2019, DOI). Dynasore's ability to block these processes enables precise mechanistic studies of cellular uptake, synaptic transmission, and disease mechanisms, including pathogen entry and tumor microenvironment modulation.

Mechanism of Action of Dynasore

Dynasore is a cell-permeable, noncompetitive inhibitor targeting the GTPase activity of dynamin1, dynamin2, and Drp1. It binds outside the GTP-binding pocket, preventing GTP hydrolysis and subsequent membrane scission events. The compound exhibits an IC50 of 15 µM for dynamin GTPase inhibition. By blocking dynamin-dependent endocytosis, Dynasore disrupts transferrin uptake, synaptic vesicle recycling, and internalization of certain pathogens (Wei et al., 2019, DOI). Inhibition is reversible, allowing temporal control in experimental setups. APExBIO supplies Dynasore (SKU A1605) as a solid, recommending dissolution in DMSO (≥16.12 mg/mL) and storage at -20°C (product details).

Evidence & Benchmarks

• Dynasore (15 µM) robustly blocks dynamin-dependent endocytosis in Drosophila S2 cells, significantly reducing pathogen (Spiroplasma eriocheiris) internalization (Wei et al., 2019, DOI).
• Reversible inhibition of transferrin uptake and synaptic vesicle recycling by Dynasore is demonstrated in HL-1 cells, neurons, and model organisms (APExBIO).
• Dynasore displays high selectivity for dynamin GTPases over related GTPases, supporting its use in dissecting dynamin-specific pathways (internal article).
• Disruption of cellular cholesterol with methyl-β-cyclodextrin and nystatin does not affect Spiroplasma eriocheiris infection, confirming that Dynasore’s inhibition is specific to clathrin-mediated pathways and not caveolae-mediated endocytosis (Wei et al., 2019, DOI).

This article extends the scenario-driven guidance in Dynasore (SKU A1605): Reliable Dynamin GTPase Inhibition by presenting peer-reviewed primary data from invertebrate and mammalian models. It also updates the mechanistic context beyond the applications discussed in Dynasore in Cancer and Microbiome Research by incorporating recent pathogen-host interaction findings.

Applications, Limits & Misconceptions

Dynasore is widely used in basic and translational research:

• Dissecting clathrin-mediated endocytosis and vesicle trafficking in live cells.
• Studying synaptic vesicle recycling in neurobiology and neurodegenerative disease models (internal review).
• Evaluating signal transduction and protein biosynthesis by modulating membrane protein internalization.
• Modeling pathogen entry mechanisms and screening for anti-infective strategies.
• Exploring cancer cell adaptation to microenvironmental changes via vesicle trafficking (internal article).

Common Pitfalls or Misconceptions

• Dynasore does not inhibit caveolae-mediated endocytosis; its action is specific to dynamin-dependent pathways (Wei et al., 2019, DOI).
• The compound is insoluble in water or ethanol; improper stock preparation may lead to precipitation and experimental variability (APExBIO).
• Dynasore is not suitable for in vivo therapeutic use; it is intended solely for in vitro and ex vivo research.
• Non-dynamin GTPases are not significantly inhibited at working concentrations; off-target effects are minimal but should be validated for new models.
• Dynasore's inhibition is reversible; continuous presence is required for sustained pathway blockade.

Workflow Integration & Parameters

For optimal use, dissolve Dynasore in DMSO at concentrations ≥16.12 mg/mL. Warm solutions to 37°C or sonicate to enhance solubility. Store aliquots at -20°C for up to several months. In cellular assays, effective working concentrations are typically 10–80 µM; the IC50 is 15 µM for dynamin GTPase inhibition. Apply stock solutions directly to culture medium, ensuring DMSO concentrations remain below cytotoxic thresholds (usually ≤0.5%). Use reversible inhibition for time-course and washout experiments. Always consult the APExBIO Dynasore datasheet for up-to-date handling protocols and safety precautions.

Conclusion & Outlook

Dynasore, from APExBIO, is a rigorously validated noncompetitive inhibitor of dynamin GTPases, enabling precise dissection of endocytic and vesicle trafficking pathways. Its specificity, reversibility, and robust experimental benchmarks make it indispensable for research in signal transduction, cancer biology, neurodegeneration, and host-pathogen interactions. Future studies may refine its utility in high-content screening and multiplexed pathway analysis, but its current role as a standard endocytosis inhibitor is well-established and growing (Wei et al., 2019).